MktsMarkets

Co-Diagnostics, Inc.
NASDAQ: CODXKey statistics
CODX News
Stories mentioning CODX from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 146.00 | 264.00 | 145.00 | 163.00 | 50.00 | 149.00 | 641.00 | 2,657 |
| Cost of Goods Sold | 194.00 | 142.00 | 26.00 | 32.00 | 22.00 | 255.00 | 297.00 | 212.00 |
| Gross Profit | (48.00) | 121.00 | 119.00 | 131.00 | 29.00 | (106.00) | 344.00 | 2,445 |
| Operating Expenses | ||||||||
| Research & Development | 5,934 | 5,099 | 4,481 | 4,687 | 4,870 | 4,807 | 4,880 | 5,613 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | 9,161 | 26,662 | 7,133 | 8,189 | 8,581 | 11,800 | 10,579 | 10,125 |
| Operating Income (Loss) | (9,208) | (26,541) | (7,014) | (8,058) | (8,552) | (11,907) | (10,235) | (7,680) |
| Interest Income | ||||||||
| Interest Expense | ||||||||
| Other Expense | ||||||||
| Pretax Income | (9,140) | (26,220) | (7,053) | (7,718) | (7,521) | (11,040) | (9,674) | (7,579) |
| Tax Provision | 1.00 | (473.00) | (1,167) | 12.00 | 12.00 | (9.00) | 22.00 | 21.00 |
| Net Income (Loss) | (9,140) | (25,746) | (5,887) | (7,730) | (7,533) | (11,032) | (9,696) | (7,599) |
| Earnings Per Share (Basic) | (4.06) | (19.36) | (0.16) | (0.23) | (7.05) | (10.91) | (0.32) | (0.25) |
| Earnings Per Share (Diluted) | (4.06) | (19.36) | (0.16) | (0.23) | (7.05) | (10.91) | (0.32) | (0.25) |
| Weighted Average Shares Outstanding (Basic) | 2,253 | 1,330 | 37,891 | 33,108 | 1,068 | 1,011 | 30,494 | 30,125 |
| Weighted Average Shares Outstanding (Diluted) | 2,253 | 1,330 | 37,891 | 33,108 | 1,068 | 1,011 | 30,494 | 30,125 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About CODX
Co-Diagnostics, Inc. (NASDAQ: CODX) is a stock listed on the Nasdaq Stock Market under the ticker symbol CODX. It last traded at $0.2300 (Nov 16, 2026, 10:05 AM ET), down 11.3% on the day. That gives Co-Diagnostics a market capitalisation of $2.7M.
Over the past 52 weeks CODX has traded between $0.2400 and $13.54.
Revenue for the quarter ended Mar 31, 2026 was $146.0K; a net loss of $9.1M. Revenue was up 192% from $50.0K in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $146.0K | -$9.1M | -6260.3% |
| Dec 31, 2025 | $264.0K | -$25.7M | -9752.3% |
| Sep 30, 2025 | $145.0K | -$5.9M | -4060.0% |
| Jun 30, 2025 | $163.0K | -$7.7M | -4742.3% |
From Co-Diagnostics’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…